申请人:——
公开号:US20040110754A1
公开(公告)日:2004-06-10
The present invention provides novel arylcyclopropylcarboxylic amides and related derivatives having the general Formula I
1
wherein R, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and R
7
are as defined in the specification, or a nontoxic pharmaceutically acceptable salt, solvate or hydrate thereof which are openers or activators of KCNQ potassium channels. The present invention also provides pharmaceutical compositions comprising said arylcyclopropylcarboxylic amides and to the method of treatment of disorders sensitive to KCNQ potassium channel opening activity such as migraine or a migraine attack, bipolar disorders, epilepsy, acute and chronic pain and anxiety.
本发明提供了具有一般式I1的新型芳基环丙基羧酰胺和相关衍生物,其中R、R1、R2、R3、R4、R5、R6和R7如规范中所定义,或其无毒的药学上可接受的盐、溶剂或水合物,这些化合物是KCNQ钾通道的开启剂或激活剂。本发明还提供了包括上述芳基环丙基羧酰胺的药物组合物,以及治疗对KCNQ钾通道开启活性敏感的疾病的方法,如偏头痛或偏头痛发作、双相障碍、癫痫、急性和慢性疼痛以及焦虑症。